ClinicalTrials.Veeva

Menu

Stent Versus Conservative Treatment in Patients With Deep Venous Obstruction (STEVECO)

Maastricht University Medical Centre (MUMC) logo

Maastricht University Medical Centre (MUMC)

Status

Terminated

Conditions

Deep-Venous Thrombosis
Randomized Clinical Trial
Deep Venous Stenting

Treatments

Device: deep venous stenting

Study type

Interventional

Funder types

Other

Identifiers

NCT03026049
RCT DVO

Details and patient eligibility

About

Patients will be randomised between deep venous stenting or conservative management

Enrollment

65 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age >18 years
  • Meet criteria for PTS or
  • Patients with May Thurner syndrome on additional imaging
  • Life expectancy of more than one year
  • Deep venous thrombosis > 1 year
  • Signed informed consent

Exclusion criteria

  • Previous intervention of central veins (inferior vena cava, iliac veins, common femoral vein) on the affected limb
  • Known pregnancy
  • Inability to answer Dutch QoL questionnaires or limited communication in Dutch (written and spoken)
  • Contra-indication for prolonged anticoagulant treatment
  • Recent, <1 year, deep venous thrombosis or pulmonary Embolism
  • Known contrast allergy
  • Known dialysis or renal insufficiency needing additional preparation for injection of contrast

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

65 participants in 2 patient groups

deep venous stent
Active Comparator group
Description:
Patients will receive deep venous stenting in the iliaco(femoral) region
Treatment:
Device: deep venous stenting
conservative managment
No Intervention group
Description:
Conservative management of complaints

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems